Suchergebnisse - "Bylicki, Olivier"

PubPharm (70)

11

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

12

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

13

Correction to: First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

14

Lung cancer trends and tumor characteristic changes over 20 years (2000-2020) : Results of three French consecutive nationwide prospective cohorts' studies

enthalten in: The Lancet regional health. Europe | 2022

von Debieuvre, D. | Molinier, O. | Falchero, L. | +117

15

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors : New Combinations and Long-Term Data

enthalten in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

ErratumIn: BioDrugs. 2023 Jan;37(1):121. - PMID 36401075

16

Single-centre experience of transbronchial cryobiopsy as a first choice method for the diagnosis of interstitial lung disease

enthalten in: Indian journal of thoracic and cardiovascular surgery | 2022

von Rivière, F. | Cazes, A. | Bylicki, O. | +6

17

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

18

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

19

First-Line Treatment of Advanced Non-Small-Cell Lung Cancer with Immune-Checkpoint Inhibitors: New Combinations and Long-Term Data

enthalten in: BioDrugs | 2022

von Boussageon, M. | Swalduz, A. | Chouaïd, C. | +1

20

ROS-1 Fusions in Non-Small-Cell Lung Cancer : Evidence to Date

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Gendarme, S. | Bylicki, O. | Chouaid, C. | +1